Rainbow Children's Medicare Limited

NSE RAINBOW.NS

Rainbow Children's Medicare Limited Price to Sales Ratio (P/S) on January 14, 2025: 10.99

Rainbow Children's Medicare Limited Price to Sales Ratio (P/S) is 10.99 on January 14, 2025, a -0.07% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Rainbow Children's Medicare Limited 52-week high Price to Sales Ratio (P/S) is 12.92 on December 04, 2024, which is 17.56% above the current Price to Sales Ratio (P/S).
  • Rainbow Children's Medicare Limited 52-week low Price to Sales Ratio (P/S) is 8.62 on July 24, 2024, which is -21.56% below the current Price to Sales Ratio (P/S).
  • Rainbow Children's Medicare Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 10.68.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
NSE: RAINBOW.NS

Rainbow Children's Medicare Limited

CEO Dr. Ramesh Kancharla M. D. Peds
IPO Date May 10, 2022
Location India
Headquarters 8-2-19/1/A, Daulet Arcade
Employees 3,940
Sector Health Care
Industries
Description

Rainbow Children's Medicare Limited operates a multi-specialty pediatric and obstetrics, and gynecology hospital chain in India. The company's child health services include general pediatrics, neonatalogy, surgery, gastroenterology and liver diseases, hematology and oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrition, psychiatry, ENT, cardiology, radiology, physiotherapy and rehabilitation, orthopedics, urology, ophthalmology, dermatology, allergy, neurosurgery, rheumatology, infectious disease, and cranio-maxillofacial surgery; intensive care unit, bone marrow transplant unit, anesthesia and pain management, kidney transplant, cochlear implant services; genetics and metabolic medicines; and laboratory, speech and language therapy, occupational therapy, pediatric and metabolic medicine, developmental and behavioral pediatrics, cerebral palsy care services. Its women health services include obstetrics and gynecology, painless delivery and labor, high risk pregnancy, pregnancy and delivery, childbirth preparation classes, vaginal birth after cesarean, breast feeding support, well women checkup, urogynecology, pre-pregnancy health checkup, minimally invasive surgery, breast care, fetal medicine, menopausal treatment, new-born care, women's nutrition, and diabetology. The company also provides fertility care services, such as fertility treatment, ovulation induction, intracytoplasmic sperm injection treatment, investigation, intrauterine insemination, intracytoplasmic morphologically selected sperm injection, assisted hatching, cryopreservation, sperm and oocyte donor treatments, frozen embryo transfer, surgical sperm retrieval, embryo donor treatments, reproductive surgery, pre-conception counselling, and andrology and urology. As of December 31, 2021, it operated 14 hospitals and 3 clinics in 6 cities with a total of 1,500 beds. The company was incorporated in 1998 and is based in Hyderabad, India.

Similar companies

SAPPHIRE.NS

Sapphire Foods India Limited

USD 3.76

1.68%

VIJAYA.NS

Vijaya Diagnostic Centre Limited

USD 13.39

-3.61%

KIMS.NS

Krishna Institute of Medical Sciences Limited

USD 7.15

0.36%

MEDPLUS.NS

MedPlus Health Services Limited

USD 8.96

-4.78%

CAMPUS.NS

Campus Activewear Limited

USD 3.28

4.81%

StockViz Staff

January 15, 2025

Any question? Send us an email